Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mass General Brigham Cancer Center is a premier integrated cancer care and research system that unites the oncology programs of Massachusetts General Hospital and Brigham and Women's Hospital. As a founding member of the Mass General Brigham healthcare system and a principal teaching affiliate of Harvard Medical School, the center provides comprehensive clinical care across all oncology specialties. It is a global leader in translational research, hosting over 1,000 active clinical trials and pioneering advancements in immunotherapy, precision medicine, and advanced surgical techniques. The center's multidisciplinary approach integrates basic science with clinical application to improve outcomes for diverse cancer populations. Its robust infrastructure supports the development of novel diagnostics and therapeutics, serving as a central hub for the Boston biotechnology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mass General Brigham Cancer Center.